Concepedia

Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events

Siew C. Ng, Ye Peng, Lin Zhang, Chris KP Mok, Shilin Zhao, Amy Li, Jessica Y. L. Ching, Yingzhi Liu, Shuai Yan, Dream L S Chan,

Gut · 2022 · 174 citations · 42 references

DOIFull text

Open access

Abstract

Our study has identified specific gut microbiota markers in association with improved immune response and reduced adverse events following COVID-19 vaccines. Microbiota-targeted interventions have the potential to complement effectiveness of COVID-19 vaccines.

References

42

Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes

Gary D. Wu, Jun Chen, Christian Hoffmann et al. · Science · 2011 · 6.4K citations · Full text

, , +17

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury, Deborah Cromer, Arnold Reynaldi et al. · Nature Medicine · 2021 · 4.1K citations · Full text

, , +7

Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study

Qifang Bi, Yongsheng Wu, Shujiang Mei et al. · The Lancet Infectious Diseases · 2020 · 2K citations · Full text

, , +9

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

Eric J. Haas, Frederick J. Angulo, John M. McLaughlin et al. · The Lancet · 2021 · 1.7K citations · Full text

, , +9